Köbel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, Gilks CB (2010) Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol 29:203–211

Article  PubMed  Google Scholar 

Prat J, D’Angelo E, Espinosa I (2019) Ovarian carcinomas: at least five different diseases with distinct histological features and molecular. Hum Pathol 80:11–27

Article  Google Scholar 

Peres LC, Cushing-Haugen KL, Köbel M et al (2019) Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst 111:60–68

Article  PubMed  Google Scholar 

McCluggage WG (2012) Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. J Clin Pathol 65:596–600

Article  PubMed  Google Scholar 

Kurman RJ, Shih I-M (2016) The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 186:733–747

Article  PubMed  PubMed Central  Google Scholar 

Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM (2004) The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 23:41–44

Article  PubMed  Google Scholar 

Yoshikawa N, Kajiyama H, Mizuno M, Shibata K, Kawai M, Nagasaka T, Kikkawa F (2014) Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women. J Gynecol Oncol 25:118–123

Article  PubMed  PubMed Central  Google Scholar 

Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA (2019) Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst 111:60–68

Article  PubMed  Google Scholar 

Carbonnel M, Layoun L, Poulain M, Tourne M, Murtada R, Grynberg M, Feki A, Ayoubi JM (2021) Serous borderline ovarian tumor diagnosis, management and fertility preservation in young women. J Clin Med 10(18):4233

Article  PubMed  PubMed Central  Google Scholar 

McGuire V, Jesser CA, Whittemore AS (2002) Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol 84:399–403

Article  PubMed  Google Scholar 

Yemelyanova AV, Vang R, Judson K et al (2008) Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Path 32:128–138

Article  PubMed  Google Scholar 

Seidman JD, Kurman RJ, Ronnett BM (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 27:985–993

Article  PubMed  Google Scholar 

Zaino RJ, Brady MF, Lele SM et al (2011) Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study. Cancer 117:554–562

Article  PubMed  Google Scholar 

Clement PB, Young RH (2014) Atlas of gynecologic surgical pathology, 3rd edn. Elsevier, Amsterdam, The Netherlands

Google Scholar 

Tuxen MK, Sölétormos G, Dombernowsky P (1995) Tumor markers in the management of patients with ovarian cancer. Cancer Treat Rev 21:215–245

Article  CAS  PubMed  Google Scholar 

Tamakoshi K, Kikkawa F, Shibata K et al (1996) Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Gynecol Oncol 62:67–72

Article  CAS  PubMed  Google Scholar 

Cho HY, Kyung MS (2014) Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study. Med Sci Monit 20:1334–1339

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morice P, Gouy S, Leary A (2019) Mucinous ovarian carcinoma. N Engl J Med 380:1256–1266

Article  CAS  PubMed  Google Scholar 

Hoogendam JP, Vlek CA, Witteveen PO, Verheijen RHM, Zweemer RP (2017) Surgical lymph node assessment in mucinous ovarian carcinoma staging: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol 124:370–378

Article  CAS  Google Scholar 

Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD (2018) Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. J Gynecol Oncol 29:1–15

Article  Google Scholar 

Muyldermans K, Moerman P, Amant F, Leunen K, Neven P, Vergote I (2013) Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases. Eur J Cancer 49:1600–1608

Article  CAS  PubMed  Google Scholar 

Ozcan A, Töz E, Turan V, Sahin C, Kopuz A, Ata C, Sancı M (2015) Should we remove the normal-looking appendix during operations for borderline mucinous ovarian neoplasms?: A retrospective study of 129 cases. Int J Surg 18:99–103

Article  PubMed  Google Scholar 

Cheng A, Li M, Kanis MJ, Xu Y, Zhang Q, Cui B, Jiang J, Zhang Y, Yang X, Kong B (2017) Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis. Gynecol Oncol 144:215–222

Article  PubMed  Google Scholar 

Rosendahl M, Haueberg Oester LA, Høgdall CK (2017) The importance of appendectomy in surgery for mucinous adenocarcinoma of the ovary. Int J Gynecol Cancer 27:430–436

Article  PubMed  Google Scholar 

Bentivegna E, Fruscio R, Roussin S, Ceppi L, Satoh T, Kajiyama H, Uzan C, Colombo N, Gouy S, Morice P (2015) Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients. Fertil Steril 104:1319–1324

Article  PubMed  Google Scholar 

Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P (2018) Results of fertility-sparing surgery for expansile and infiltrative mucinous ovarian cancers. Oncologist 23:324–327

Article  PubMed  Google Scholar 

Rodríguez IM, Prat J (2002) Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol 26:139–152

Article  PubMed  Google Scholar 

Gore ME, Hackshaw A, Brady WE, Penson RT, Zaino RJ, McCluggage WG, Ganesan R, Wilkinson N, Perren T, Montes A et al (2015) Multicentre trial of carboplatin/paclitaxel versus oxaliplatin/capecitabine, each with/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC). J Clin Oncol 33:5528

Article  Google Scholar 

Nasioudis D, Haggerty AF, Giuntoli RL, Burger RA, Morgan MA, Ko EM, Latif NA (2019) Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma. Gynecol Oncol 154:302–307

Article  PubMed  Google Scholar 

Kajiyama H, Suzuki S, Utsumi F, Yoshikawa N, Nishino K, Ikeda Y, Niimi K, Yamamoto E, Kawai M, Shibata K et al (2019) Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma. Int J Clin Oncol 24:950–956

Article  PubMed  Google Scholar 

Xu W, Rush J, Rickett K, Coward JIG (2016) Mucinous ovarian cancer: a therapeutic review. Crit Rev Oncol Hematol 102:26–36

Article  PubMed  Google Scholar 

Trimble CL, Kosary C, Trimble EL (2002) Long term survival and patterns of care in women with ovarian carcinoma: a population based analysis. Gynecol Oncol 86:34–37

Article  PubMed  Google Scholar 

Sahraoui G, Fitouri A, Charfi L, Driss M, Slimane M, Hechiche M, Mrad K, Doghri R (2022) Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute. Pan Afr Med J 29(41):349

Google Scholar